Skip to search formSkip to main contentSkip to account menu

olpadronate

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

olpadronic acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats.
2005
2005
Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease.
Thirty male adult Wistar rats (300-/+10 g body weight) underwent either 5/6 nephrectomy (Nx, n=20) or sham operation (SHAM, n=10… 
2004
2004
Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover
The activity of olpadronate labelled with technetium-99m(99mTc) was monitored in plasma and urine samples after single oral (925… 
2003
2003
Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapy.
2002
2002
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton
Abstract. Spinal cord compression (SCC) is a devastating complication of metastatic cancer. We investigated the potential… 
2001
2001
Olpadronate Prevents the Bone Loss Induced by Cyclosporine in the Rat
The aim of the present in vivo experimental study was to investigate changes in bone turnover and bone mineral density (BMD… 
2001
2001
Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.
Fibrous dysplasia of bone is a rare disease related to a genetic mutation in which bone formation at osseous sites is altered. In… 
1999
1999
Short‐Term Therapy with Oral Olpadronate in Active Paget's Disease of Bone
One of the aims of the treatment of Paget's disease with bisphosphonates should be the normalization of the activity of the… 
1997
1997
[Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
Bisphosphonates are the treatment of choice in patients with Paget's disease. However in patients with an extensive disease it… 
1995
1995
High-performance ion-exchange chromatography with in-line complexation of bisphosphonates and their quality control in pharmaceutical preparations.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)